Hana Pharm Co Ltd (293480) — Cash Flow Quality Index
Hana Pharm Co Ltd (293480) has a Cash Flow Quality Index of 0.04x as of June 2025. Operating cash flow of ₩235.15 Million is below net income of ₩5.53 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Hana Pharm Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hana Pharm Co Ltd Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for Hana Pharm Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 293480 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Hana Pharm Co Ltd (2016–2024)
Year-by-year earnings quality comparison for Hana Pharm Co Ltd. For live market cap and the full company financial profile, see Hana Pharm Co Ltd stock valuation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.19x | ₩25.30 Billion | ₩21.25 Billion | ▲ +44.5% |
| 2023 | 0.82x | ₩18.40 Billion | ₩22.33 Billion | ▼ -35.1% |
| 2022 | 1.27x | ₩30.88 Billion | ₩24.31 Billion | ▲ +38.7% |
| 2021 | 0.92x | ₩25.66 Billion | ₩28.01 Billion | ▼ -12.5% |
| 2020 | 1.05x | ₩15.58 Billion | ₩14.89 Billion | ▼ -6.6% |
| 2019 | 1.12x | ₩31.72 Billion | ₩28.30 Billion | ▲ +6.3% |
| 2018 | 1.05x | ₩27.59 Billion | ₩26.17 Billion | ▲ +0.9% |
| 2017 | 1.04x | ₩25.38 Billion | ₩24.30 Billion | ▲ +46.0% |
| 2016 | 0.72x | ₩12.46 Billion | ₩17.43 Billion | — |